BioCentury
ARTICLE | Company News

Alacris Theranostics, GlaxoSmithKline deal

December 3, 2012 8:00 AM UTC

The companies partnered to apply Alacris' ModCell system to early stage cancer drug development. GlaxoSmithKline will provide Alacris preclinical data from a cancer compound. Alacris will then use its...